Concepedia

Yan Hao

YH

8

Publications

200

Citations

8

H-Index

2011

Active since

Affiliations

Eli Lilly (United States)(Current)

Hong Kong University of Science and Technology

University of Hong Kong

Chinese Academy of Sciences

Yan Hao is an author at Eli Lilly (United States) specializing in cancer research, molecular imaging, and tumor biology.

ORCID

Top concepts

Publications per year

2011–2020

8

Publications

8

Dietary fatty acids promote lipid droplet diversity through seipin enrichment in an ER subdomain

Zhe Cao, Yan Hao, Chun Wing Fung et al. · Nature Communications · 2019 · 73 citations · Full text

Notoginsenoside R1 alleviates high glucose-evoked damage in RSC96 cells through down-regulation of miR-503

Weiwei Wang, Yan Hao, Feng Li · Artificial Cells Nanomedicine and Biotechnology · 2019 · 27 citations · Full text

TALPID3 and ANKRD26 selectively orchestrate FBF1 localization and cilia gating

Yan Hao, Chuan Chen, Huicheng Chen et al. · Nature Communications · 2020 · 25 citations · Full text

ER81 Expression in Breast Cancers and Hyperplasia

Yuan-yuan Wang, Li Wang, Yue Chen et al. · Pathology Research International · 2011 · 20 citations · Full text

Discovery of LY2457546: a multi-targeted anti-angiogenic kinase inhibitor with a novel spectrum of activity and exquisite potency in the acute myelogenous leukemia-Flt-3-internal tandem duplication mutant human tumor xenograft model

Timothy P. Burkholder, Joshua R. Clayton, Mark E. Rempala et al. · Investigational New Drugs · 2011 · 17 citations

, , +11

Rows per page

1–5 of 8